Characteristics, prevalence of chronic HBV and associated factors among oHGRs
| Overall n=141 903 | HBsAg prevalence (%) | Crude OR (95% CI) | P value* | Adjusted OR (95% CI) | P value† | |
| Characteristics | Tested n=140 985 (%) | 5707 (4.0) | ||||
| Age | ||||||
| 15–24 | 10 858 (7.7) | 384 (3.5) | 1 | <0.001 | 1 | <0.001 |
| 25–34 | 13 922 (9.9) | 700 (5.0) | 1.44 (1.27 to 1.64) | 1.40 (1.23 to 1.61) | ||
| 35–44 | 11 764 (8.3) | 626 (5.3) | 1.53 (1.35 to 1.74) | 1.54 (1.34 to 1.77) | ||
| 45–54 | 43 254 (30.7) | 1 768 (4.1) | 1.16 (1.04 to 1.30) | 1.18 (1.04 to 1.34) | ||
| 55–64 | 33 529 (23.8) | 1 235 (3.7) | 1.04 (0.93 to 1.17) | 1.06 (0.93 to 1.21) | ||
| 65+ | 27 658 (19.6) | 994 (3.6) | 1.02 (0.90 to 1.15) | 1.06 (0.92 to 1.21) | ||
| Unknown | 918 (0.6) | |||||
| Sex | ||||||
| Male | 50 417 (35.8) | 2 549 (5.1) | 1 | <0.001 | 1 | <0.001 |
| Female | 90 416 (64.2) | 3 154 (3.5) | 0.68 (0.64 to 0.71) | 0.72 (0.68 to 0.77) | ||
| Unknown | 1 070 (0.8) | |||||
| Socioeconomic status | ||||||
| Poorer | 18 133 (14.3) | 648 (3.6) | 1 | 0.003 | Not analysed | |
| Poor | 45 486 (35.8) | 1 758 (3.9) | 1.08 (0.99 to 1.19) | |||
| Rich | 63 062 (49.6) | 2 601 (4.1) | 1.16 (1.06 to 1.27) | |||
| Richer | 388 (0.3) | 11 (2.8) | 0.79 (0.43 to 1.44) | |||
| Unknown | 14 834 (10.0) | |||||
| Health insurance | ||||||
| No | 470 (0.3) | 23 (4.9) | Not analysed | Not analysed | ||
| Yes | 137 391 (99.7) | 5 562 (4.0) | ||||
| Unknown | 4 042 (2.8) | |||||
| Province | ||||||
| South | 29 626 (21.0) | 838 (2.8) | 1 | <0.001 | 1 | <0.001 |
| Kigali | 15 963 (11.3) | 614 (3.8) | 1.37 (1.24 to 1.53) | 1.29 (1.15 to 1.45) | ||
| East | 32 873 (23.3) | 1 528 (4.6) | 1.67 (1.54 to 1.82) | 1.58 (1.44 to 1.73) | ||
| West | 43 613 (30.9) | 1 770 (4.1) | 1.45 (1.34 to 1.58) | 1.36 (1.24 to 1.49) | ||
| North | 18 910 (13.4) | 957 (5.1) | 1.83 (1.66 to 2.01) | 1.84 (1.66 to 2.03) | ||
| Unknown | 918 (0.6) | |||||
| Anti-HCV | ||||||
| Negative | 127 787 (90.9) | 5 393 (4.2) | 1 | <0.001 | 1 | <0.001 |
| Positive | 12 718 (9.10) | 299 (2.4) | 0.55 (.043 to 0.04) | 0.58 (0.51 to 0.66) | ||
| Unknown | 1 398 (1.00) |
*χ2 p value.
†Likelihood ratio test p value (compare models with and without variable).
HBsAg, hepatitis B surface antigens; HBV, hepatitis B virus; HCV, hepatitis C virus; oHGRs, other high-risk groups.